Search Results - "Ketterer, Knut"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Pancreatic cancerrelated cachexia: influence on metabolism and correlation to weight loss and pulmonary function by Bachmann, Jeannine, Ketterer, Knut, Marsch, Christiane, Fechtner, Kerstin, Krakowski-Roosen, Holger, Büchler, Markus W, Friess, Helmut, Martignoni, Marc E

    Published in BMC cancer (28-07-2009)
    “…Background Dramatic weight loss is an often underestimated symptom in pancreatic cancer patients. Cachexia- defined as an unintended loss of stable weight…”
    Get full text
    Journal Article
  2. 2

    Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis by ERKAN, Mert, KLEEFF, Jorg, ESPOSITO, Irene, GIESE, Thomas, KETTERER, Knut, BÜCHLER, Markus W, GIESE, Nathalla A, FRIESS, Helmut

    Published in Oncogene (23-06-2005)
    “…Altered expression of apoptosis-regulating genes plays an important role in the aggressive growth behavior and chemoresistance of pancreatic ductal…”
    Get full text
    Journal Article
  3. 3

    Reverse Transcription-PCR Analysis of Laser-Captured Cells Points to Potential Paracrine and Autocrine Actions of Neurotrophins in Pancreatic Cancer by KETTERER, Knut, SHYAM RAO, FRIESS, Helmut, WEISS, John, BIICHLER, Markus W, KORC, Murray

    Published in Clinical cancer research (01-11-2003)
    “…Purpose: Neurotrophins (NTs) can stimulate cell proliferation and differentiation in various cell types, and play a role in certain human cancers. In this…”
    Get full text
    Journal Article
  4. 4

    Indian hedgehog signaling pathway: Expression and regulation in pancreatic cancer by Kayed, Hany, Kleeff, Jörg, Keleg, Shereen, Guo, Junchau, Ketterer, Knut, Berberat, Pascal O., Giese, Nathalia, Esposito, Irene, Giese, Thomas, Büchler, Markus W., Friess, Helmut

    Published in International journal of cancer (10-07-2004)
    “…Pancreatic cancer is an aggressive malignancy that exhibits a number of genetic and epigenetic alterations. Indian hedgehog (Ihh) and its 2 signaling…”
    Get full text
    Journal Article
  5. 5

    FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth by Kayed, Hany, Kleeff, Jörg, Kolb, Armin, Ketterer, Knut, Keleg, Shereen, Felix, Klaus, Giese, Thomas, Penzel, Roland, Zentgraf, Hanswalter, Büchler, Markus W., Korc, Murray, Friess, Helmut

    Published in International journal of cancer (01-01-2006)
    “…The expression and localization of FXYD domain containing ion transport regulator 3 (FXYD3), a transmembrane protein that acts as a chloride channel or…”
    Get full text
    Journal Article
  6. 6

    Liver macrophages contribute to pancreatic cancer-related cachexia by MARTIGNONI, Marc E, DIMITRIU, Corneliu, BACHMANN, Jeaninne, KRAKOWSKI-ROSEN, Holger, KETTERER, Knut, KINSCHERF, Ralf, FRIESS, Helmut

    Published in Oncology reports (01-02-2009)
    “…Cachexia is a devastating process especially in pancreatic cancer patients and contributes to their poor survival. We attempted to clarify the pathological and…”
    Get full text
    Journal Article
  7. 7

    Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway by Ketterer, Knut, Kong, Bo, Frank, Dietwalt, Giese, Nathalia A, Bauer, Andrea, Hoheisel, Jörg, Korc, Murray, Kleeff, Jörg, Michalski, Christoph W, Friess, Helmut

    Published in Cancer letters (08-05-2009)
    “…Abstract Neuromedin U (NmU) is a bioactive peptide, ubiquitously expressed in the gastrointestinal tract. Here, we analyzed the role of NmU in pancreatic…”
    Get full text
    Journal Article
  8. 8

    Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis by Guweidhi, Ahmed, Kleeff, Jörg, Giese, Nathalia, Fitori, Jamael El, Ketterer, Knut, Giese, Thomas, Büchler, Markus W., Korc, Murray, Friess, Helmut

    Published in Carcinogenesis (New York) (01-09-2004)
    “…14-3-3sigma belongs to the 14-3-3 family of proteins, which are involved in the modulation of diverse signal transduction pathways. Loss of 14-3-3sigma…”
    Get full text
    Journal Article
  9. 9

    Thioredoxin is downstream of Smad7 in a pathway that promotes growth and suppresses cisplatin-induced apoptosis in pancreatic cancer by ARNOLD, Nichole Boyer, KETTERER, Knut, KLEEFF, Jörg, FRIESS, Helmut, BÜCHLER, Markus W, KORC, Murray

    Published in Cancer research (Chicago, Ill.) (15-05-2004)
    “…Pancreatic ductal adenocarcinoma (PDAC) is an aggressive human malignancy in which Smad7 is commonly overexpressed. Analysis by differential display identified…”
    Get full text
    Journal Article
  10. 10

    Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function by Bachmann, Jeannine, Ketterer, Knut, Marsch, Christiane, Fechtner, Kerstin, Krakowski-Roosen, Holger, Büchler, Markus W, Friess, Helmut, Martignoni, Marc E

    Published in BMC cancer (28-07-2009)
    “…Dramatic weight loss is an often underestimated symptom in pancreatic cancer patients. Cachexia- defined as an unintended loss of stable weight exceeding…”
    Get full text
    Journal Article
  11. 11
  12. 12